Corporate Health Checkup Packages Skip These Critical Screening Tests Every Indian Employee Needs

Most employer-sponsored health checkup packages in India run on a template that has barely changed in two decades. A complete blood count, fasting blood sugar, lipid profile, liver function tests, a chest X-ray, and blood pressure measurement. Some add an ECG for employees over forty. The whole thing takes ninety minutes and produces a report that looks dense but measures almost nothing about how your body is actually functioning at the cellular or hormonal level.
A 2022 study published in the Indian Journal of Endocrinology and Metabolism found that nearly 76% of urban Indian adults screened in workplace settings had at least one micronutrient deficiency, most commonly Vitamin D, Vitamin B12, or iron, that went undetected because standard corporate panels do not test for them. The tests exist. The cost of adding them is marginal. They are simply not included.
Vitamin D deficiency affects an estimated 70 to 90% of the Indian population, according to data published in the Journal of Family Medicine and Primary Care. Sitting in an office under fluorescent light for eight hours a day does not help. Yet a serum 25-hydroxyvitamin D test, the only reliable way to measure your actual Vitamin D status, appears in almost no corporate checkup package. The same is true for Vitamin B12, which is critical for nerve function and is deficient in a significant proportion of vegetarians, a dietary reality that is specifically Indian and specifically relevant to any employer running checkups in this country.
Ferritin, the protein that stores iron, is another consistent omission. A CBC will tell you whether you are anaemic today. Ferritin tells you whether you are heading toward anaemia over the next six months, and whether your fatigue, poor concentration, and hair loss have a correctable cause. These are not exotic tests. Any diagnostic lab in Pune, Hyderabad, or Kolkata runs them daily. They simply do not appear on the corporate template.Many corporate packages do include a thyroid test, but only TSH, the thyroid-stimulating hormone. TSH is a pituitary signal, not a direct measure of thyroid output. A person can have a normal TSH and still have functionally low T3 or T4 levels that explain persistent weight gain, fatigue, and cold sensitivity. Ordering TSH alone and calling it a thyroid screening is like checking whether the accelerator is pressed without looking at whether the engine is running.

Kidney function tests in standard packages typically cover serum creatinine and blood urea. These markers only become abnormal after the kidneys have already lost roughly 50% of their filtering capacity. A urine microalbumin test, which detects early kidney damage years before creatinine rises, costs under two hundred rupees at most labs and is missing from virtually every corporate panel. For a country where diabetic nephropathy is one of the leading causes of kidney failure, this omission has consequences that extend well beyond the individual employee's health report.No corporate checkup package in India includes a validated screening tool for depression or anxiety, not the PHQ-9, not the GAD-7, not even a basic self-reported questionnaire. The Employee Assistance Programmes that some larger companies offer exist separately, are often stigmatised, and are not the same as a systematic screening built into the annual health review. A blood pressure cuff gets used every year. A five-minute depression screen does not.
For women employees, the gap is sharper. Polycystic ovarian syndrome affects roughly one in five Indian women of reproductive age, according to the Indian Council of Medical Research, and its markers, testosterone, LH, FSH, AMH, are absent from standard corporate panels. Women are handed the same template as their male colleagues, a template designed around cardiovascular risk in middle-aged men, and told their health has been checked.Corporate health packages are typically negotiated between HR departments and diagnostic chains as bulk contracts. The incentive runs toward volume and optics, not clinical completeness. A package that includes twenty-five line items looks thorough in a benefits brochure even if fifteen of those items are redundant or low-yield. Adding a Vitamin D test, a ferritin test, a urine microalbumin, and a PHQ-9 would add perhaps four hundred to six hundred rupees per employee to the contract cost. That cost is real to the procurement team. The cost of the missed diagnosis is invisible to everyone except the employee who eventually pays it.

The tests that matter most for the actual disease burden of working-age Indians, deficiency screening, early kidney damage markers, thyroid depth, hormonal panels for women, mental health tools, require someone in the benefits chain to ask for them by name. The standard package will not include them until someone does.
The annual checkup report sits in a drawer or a health app, its normal ranges ticked green, its real gaps unmarked. The employee who feels exhausted, whose hair is thinning, whose concentration is slipping, walks away told they are fine. The problem is not that the tests were done and came back normal. The problem is that the tests that would have answered the actual question were never ordered.